Drug
Adstem Inj
Adstem Inj: highest development phase Phase 3, developed by EHL Bio Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- EHL Bio Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| ADSTEM Inj. NCT07377838 | Phase 3 | Atopic Dermatitis |
Latest
No recent events.
Follow Adstem Inj on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.